"Parasympatholytics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.
| Descriptor ID |
D010276
|
| MeSH Number(s) |
D27.505.696.663.050.650
|
| Concept/Terms |
Parasympatholytics- Parasympatholytics
- Parasympatholytic Drugs
- Drugs, Parasympatholytic
- Parasympathetic-Blocking Agents
- Agents, Parasympathetic-Blocking
- Parasympathetic Blocking Agents
- Parasympatholytic Agents
- Agents, Parasympatholytic
Parasympatholytic Effect- Parasympatholytic Effect
- Effect, Parasympatholytic
- Parasympatholytic Effects
- Effects, Parasympatholytic
Antispasmodic Effect- Antispasmodic Effect
- Effect, Antispasmodic
- Antispasmodic Effects
- Effects, Antispasmodic
Antispasmodics- Antispasmodics
- Antispasmodic Drugs
- Drugs, Antispasmodic
- Spasmolytics
- Antispasmodic Agents
- Agents, Antispasmodic
|
Below are MeSH descriptors whose meaning is more general than "Parasympatholytics".
Below are MeSH descriptors whose meaning is more specific than "Parasympatholytics".
This graph shows the total number of publications written about "Parasympatholytics" by people in this website by year, and whether "Parasympatholytics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Parasympatholytics" by people in Profiles.
-
Nwazue VC, Paranjape SY, Black BK, Biaggioni I, Diedrich A, Dupont WD, Robertson D, Raj SR. Postural tachycardia syndrome and inappropriate sinus tachycardia: role of autonomic modulation and sinus node automaticity. J Am Heart Assoc. 2014 Apr 10; 3(2):e000700.
-
Nakeeb A. Sphincter of Oddi dysfunction: how is it diagnosed? How is it classified? How do we treat it medically, endoscopically, and surgically? J Gastrointest Surg. 2013 Sep; 17(9):1557-8.
-
Ginsberg DA, Oefelein MG, Ellsworth PI. Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials. Neurourol Urodyn. 2011 Apr; 30(4):563-7.
-
MacDiarmid SA, Ellsworth PI, Ginsberg DA, Oefelein MG, Sussman DO. Safety and efficacy of once-daily trospium chloride extended-release in male patients with overactive bladder. Urology. 2011 Jan; 77(1):24-9.
-
Chiou E, Nurko S. Management of functional abdominal pain and irritable bowel syndrome in children and adolescents. Expert Rev Gastroenterol Hepatol. 2010 Jun; 4(3):293-304.
-
Bruzzi JF, Moss AC, Brennan DD, MacMathuna P, Fenlon HM. Efficacy of IV Buscopan as a muscle relaxant in CT colonography. Eur Radiol. 2003 Oct; 13(10):2264-70.
-
Lucchesi PA, Romano FD, Scheid CR, Yamaguchi H, Honeyman TW. Interaction of agonists and selective antagonists with gastric smooth muscle muscarinic receptors. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb; 339(1-2):145-51.
-
Hartnell GG, Hemingway AP. Contrast medium reactions--does Buscopan reduce them? Br J Radiol. 1988 Jul; 61(727):652.
-
Ferrucci JT, Benedict KT. Anticholinergic-aided study of the gastrointestinal tract. Radiol Clin North Am. 1971 Apr; 9(1):23-39.
-
Eaton SB, Benedict KT, Ferrucci JT, Fleischli DJ. Hypotonic duodenography. Radiol Clin North Am. 1970 Apr; 8(1):125-37.